Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 204

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 204
---
z Kinneret Ltd. (TASE: HOFI). From 2000
through 2002, he served as director and Chief Financial Officer of Magen David Taasiot Ltd. Mr. Sofer has a B. Sc. in Accounting and Information
Systems from the Lev Institute (Jerusalem College of Technology). We believe that Mr. Sofer’s public company and industry experience
qualify him to serve on our board of directors.

Raphi Levyhas served
as our Chief Financial Officer since 2019. Prior to joining us, Mr. Levy served in the Investment Banking Division at Goldman Sachs from
2006 until 2019 in New York and Tel Aviv, most recently serving as Executive Director in charge of healthcare banking in Israel. Mr. Levy
has served as a director of MX Management LP since April 2022. Mr. Levy holds a B. S. in Economics from the Wharton School of Business,
University of Pennsylvania, and a B. S. E. and M. S. E. in Electrical Engineering from the School of Engineering and Applied Science, University
of Pennsylvania.

Professor Yona Keisarico-founded Alpha Tau and, together with Prof. Itzhak Kelson, invented the Alpha DaRT®technology in 2003. Prof. Keisari
served as our Chief Biological Officer from 2016 until 2019 and has served as Chief Scientific Officer since 2019. Prof. Keisari was a
faculty member at the Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Israel from 1979 until
2015, and served as Full Professor from 2002 until 2015, at which time he became Professor Emeritus. Prof. Keisari’s studies focus
on the activation of systemic anti-tumor immune reactivity through in-situ destruction of solid cancers with Alpha DaRT®, and developing
means to improved eradication of metastases. Prof. Keisari has co-authored 107 peer-reviewed scientific papers and is an editorial board
member of nine journals. He co-founded and served as president of the Israeli Society for Cancer Research from 2013 until 2015 and has
served as treasurer of The International Cancer Microenvironment Society since 2015. Prof. Keisari holds an M. Sc. in Microbiology and
Immunology and a Ph. D. in Immunology from Tel Aviv University, and was a postdoctoral fellow at the